Blockchain Registration Transaction Record

Helus Pharma Partners with TARA Mind and VETS to Boost Depression Trial Recruitment

Helus Pharma partners with TARA Mind and VETS to recruit veterans for Phase 3 depression trial of breakthrough therapy HLP003, aiming to accelerate treatment for serious mental illness.

This partnership is important because it directly addresses the mental health crisis among veterans, a population with disproportionately high rates of depression and suicide. By leveraging the trusted networks of TARA Mind and VETS, Helus Pharma can accelerate recruitment for its Phase 3 trial of HLP003, potentially bringing a breakthrough therapy to market faster. If successful, this treatment could offer a new option for millions suffering from major depressive disorder who have not responded to existing therapies, highlighting the critical need for innovation in mental health care.